RxDoctor Payments DataLook up a doctor →

Hsing-Chun Hsieh, NP

Gerontology · Downey, CANPI 1003408642

Payments from drug & device makers

$9,362in general payments, 2019–2025

Across 358 payments — averaging $26.15 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novartis$2K
  • Pfizer$709
  • Merck$606
  • Bristol Myers Squibb$442
  • Takeda Pharmaceuticals U.S.A., Inc.$391
  • Bayer$386
  • plus $5K from 52 others

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Novartis37$1,727
Pfizer31$709
Merck20$606
Bristol Myers Squibb19$442
Takeda Pharmaceuticals U.S.A., Inc.13$391
Bayer15$386
Incyte Corporation25$382
Seagen Inc.9$340
GSK9$287
Gilead7$277
Sobi, Inc9$276
AbbVie19$260
Karyopharm Therapeutics Inc.9$208
Johnson & Johnson8$206
Lilly USA, LLC10$202
AstraZeneca(2 entities)11$192
E.r. Squibb & Sons, L.L.C.10$170
Beigene USA, Inc.7$166
Astellas Pharma US Inc8$162
Rigel Pharmaceuticals, Inc.5$147
Boehringer Ingelheim5$128
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)1$123
Daiichi Sankyo Inc.5$122
Puma Biotechnology, Inc.4$120
Eisai Inc.6$108
Exelixis Inc.4$101
Pharmaessentia USA Corporation3$83
EMD Serono, Inc.3$77
Genentech USA, Inc.4$73
Blueprint Medicines Corporation3$66
Amgen3$63
G1 Therapeutics, Inc.2$49
Agios Pharmaceuticals, Inc.2$47
Stemline Therapeutics Inc.2$44
Ipsen Biopharmaceuticals, Inc2$41
Morphosys, US Inc.2$41
Kyowa Kirin, Inc.2$40
Taiho Oncology, Inc.2$40
Neurocrine Biosciences, Inc.1$39
EUSA Pharma (US) LLC2$35
Genmab U.S., Inc.1$32
Adaptive Biotechnologies Corporation1$31
Myovant Sciences Inc.2$27
Recordati_rare_diseases_inc.1$25
Fennec Pharmaceuticals, Inc.1$25
Organon1$24
Clovis Oncology, Inc.1$23
Novocure Inc.1$22
Sanofi1$21
Octapharma USA, Inc.1$21
CTI Biopharma Corp.1$21
Progenics Pharmaceuticals, Inc.1$20
Chiesi USA, Inc.1$17
Immunogen, Inc.1$17
Emmaus Medical, Inc.1$17
Tolmar Pharmaceuticals, Inc.1$16
Deciphera Pharmaceuticals Inc.1$15
Mirati Therapeutics, Inc.1$14

How this compares

$9,362 in reported general payments places this provider in the 95th percentile of 348 gerontology providers in California.

See all gerontology providers in California →

Medicare billing

Part B allowed, 2024
$12,656
Medicare patients
60
Services billed
140

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other gerontology in Downey

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →